These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 8097579

  • 61. Radioimmunoassay of corticotropin-releasing hormone: methodology and clinical application.
    Suda T, Tomori N, Sumitomo T, Nakagami Y, Tozawa F, Ushiyama T, Demura H, Shizume K.
    Horm Metab Res Suppl; 1987; 16():47-51. PubMed ID: 3502116
    [Abstract] [Full Text] [Related]

  • 62. Response of serum macrophage migration inhibitory factor levels to stimulation or suppression of the hypothalamo-pituitary-adrenal axis in normal subjects and patients with Cushing's disease.
    Isidori AM, Kaltsas GA, Korbonits M, Pyle M, Gueorguiev M, Meinhardt A, Metz C, Petrovsky N, Popovic V, Bucala R, Grossman AB.
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1834-40. PubMed ID: 11932327
    [Abstract] [Full Text] [Related]

  • 63. Routine inferior petrosal sinus sampling in the differential diagnosis of adrenocorticotropin (ACTH)-dependent Cushing's syndrome: early recognition of the occult ectopic ACTH syndrome.
    Findling JW, Kehoe ME, Shaker JL, Raff H.
    J Clin Endocrinol Metab; 1991 Aug; 73(2):408-13. PubMed ID: 1649842
    [Abstract] [Full Text] [Related]

  • 64. CSF somatostatin and abnormal response to dexamethasone administration in schizophrenic and depressed patients.
    Doran AR, Rubinow DR, Roy A, Pickar D.
    Arch Gen Psychiatry; 1986 Apr; 43(4):365-9. PubMed ID: 2869743
    [Abstract] [Full Text] [Related]

  • 65. Course of depression in Cushing's syndrome: response to treatment and comparison with Graves' disease.
    Sonino N, Fava GA, Belluardo P, Girelli ME, Boscaro M.
    Horm Res; 1993 Apr; 39(5-6):202-6. PubMed ID: 8314204
    [Abstract] [Full Text] [Related]

  • 66. Corticotropin-releasing hormone: from endocrinology to psychobiology.
    Smith MA, Kling MA, Whitfield HJ, Brandt HA, Demitrack MA, Geracioti TD, Chrousos GP, Gold PW.
    Horm Res; 1989 Apr; 31(1-2):66-71. PubMed ID: 2656470
    [Abstract] [Full Text] [Related]

  • 67. A follow up study of suicide attempters: increase of CSF-somatostatin but no change in CSF-CRH.
    Westrin A, Ekman R, Regnéll G, Träskman-Bendz L.
    Eur Neuropsychopharmacol; 2001 Apr; 11(2):135-43. PubMed ID: 11313159
    [Abstract] [Full Text] [Related]

  • 68. Concentrations of corticotropin-releasing hormone, norepinephrine, MHPG, 5-hydroxyindoleacetic acid, and tryptophan in the cerebrospinal fluid of alcoholic patients: serial sampling studies.
    Geracioti TD, Loosen PT, Ebert MH, Ekhator NN, Burns D, Nicholson WE, Orth DN.
    Neuroendocrinology; 1994 Dec; 60(6):635-42. PubMed ID: 7535389
    [Abstract] [Full Text] [Related]

  • 69. Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluid.
    Roy A, Pickar D, Gold P, Barbaccia M, Guidotti A, Costa E, Linnoila M.
    Acta Psychiatr Scand; 1989 Sep; 80(3):287-91. PubMed ID: 2816471
    [Abstract] [Full Text] [Related]

  • 70. Disturbed cortisol secretion in man: contrasting Cushing's disease and endogenous depression.
    Voigt KH, Bossert S, Bretschneider S, Bliestle A, Fehm HL.
    Psychiatry Res; 1985 Aug; 15(4):341-50. PubMed ID: 2999859
    [Abstract] [Full Text] [Related]

  • 71. Serotonin, Cushing's disease, and depression.
    Sonino N, Fava GA.
    Psychother Psychosom; 1996 Aug; 65(2):63-5. PubMed ID: 8711083
    [No Abstract] [Full Text] [Related]

  • 72. Somatostatin in Alzheimer's disease and depression.
    Bissette G, Myers B.
    Life Sci; 1992 Aug; 51(18):1389-410. PubMed ID: 1357521
    [Abstract] [Full Text] [Related]

  • 73. Cerebrospinal fluid concentrations of corticotropin-releasing hormone (CRH) and corticotropin (ACTH) are reduced in patients with Alzheimer's disease.
    May C, Rapoport SI, Tomai TP, Chrousos GP, Gold PW.
    Neurology; 1987 Mar; 37(3):535-8. PubMed ID: 3029628
    [Abstract] [Full Text] [Related]

  • 74. Cerebrospinal fluid corticotropin-releasing hormone in depression: relationship to noradrenergic function.
    Roy A, Pickar D, Linnoila M, Chrousos GP, Gold PW.
    Psychiatry Res; 1987 Mar; 20(3):229-37. PubMed ID: 3495811
    [Abstract] [Full Text] [Related]

  • 75. No acute suppression of cerebrospinal fluid corticotropin-releasing hormone in man by cortisol administration.
    Kellner M, Salzwedel C, Wortmann V, Urbanowicz T, Boelmans K, Yassouridis A, Stalla GK, Wiedemann K.
    Psychiatry Res; 2013 Dec 15; 210(2):662-4. PubMed ID: 23896353
    [Abstract] [Full Text] [Related]

  • 76. Neuropeptide concentrations in the cerebrospinal fluid of depressed patients treated with electroconvulsive therapy. Corticotrophin-releasing factor, beta-endorphin and somatostatin.
    Nemeroff CB, Bissette G, Akil H, Fink M.
    Br J Psychiatry; 1991 Jan 15; 158():59-63. PubMed ID: 1673078
    [Abstract] [Full Text] [Related]

  • 77. Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients.
    Nemeroff CB, Widerlöv E, Bissette G, Walléus H, Karlsson I, Eklund K, Kilts CD, Loosen PT, Vale W.
    Science; 1984 Dec 14; 226(4680):1342-4. PubMed ID: 6334362
    [Abstract] [Full Text] [Related]

  • 78. Cerebrospinal fluid somatostatin and psychiatric illness.
    Rubinow DR.
    Biol Psychiatry; 1986 Apr 14; 21(4):341-65. PubMed ID: 2869790
    [Abstract] [Full Text] [Related]

  • 79. Cerebrospinal fluid neuropeptides in dementia.
    Banki CM, Karmacsi L, Bissette G, Nemeroff CB.
    Biol Psychiatry; 1992 Sep 01; 32(5):452-6. PubMed ID: 1486150
    [Abstract] [Full Text] [Related]

  • 80. CSF neuropeptide Y in alcoholics and normal controls.
    Roy A, Berrettini W, DeJong J, Adinoff B, Ravitz B, Linnoila M.
    Psychiatry Res; 1990 Sep 01; 33(3):215-9. PubMed ID: 1978753
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.